Cargando…
SUN-339 External Beam Radiation Therapy Improves TGFB1-Induced Mesenchymal Stem Cell-Mediated NIS Gene (131)I Therapy
The sodium iodide symporter (NIS) is the operational molecule that has allowed the efficient treatment of thyroid malignancies by the administration of (131)I for over 70 years. Various vector-driven approaches are currently under investigation to introduce the NIS gene into non-thyroidal tumors in...
Autores principales: | Schug, Christina, Kitzberger, Carolin, Sievert, Wolfgang, Spellerberg, Rebekka, Tutter, Mariella, Schmohl, Kathrin, Schwenk, Nathalie, Schwaiger, Markus, Multhoff, Gabriele, Wagner, Ernst, Nelson, Peter, Spitzweg, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553409/ http://dx.doi.org/10.1210/js.2019-SUN-339 |
Ejemplares similares
-
Taking Advantage of the TGFB1 Biology in Differentiated Thyroid Cancer to Stimulate Sodium Iodide Symporter (NIS)-Mediated Iodide Uptake in Engineered Mesenchymal Stem Cells
por: Han, Yang, et al.
Publicado: (2021) -
SUN-120 Regional Hyperthermia Enhances Selective Mesenchymal Stem Cell Migration Towards the Tumor Stroma
por: Tutter, Mariella, et al.
Publicado: (2020) -
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy
por: Kitzberger, Carolin, et al.
Publicado: (2022) -
EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases
por: Urnauer, Sarah, et al.
Publicado: (2017) -
Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes
por: Spellerberg, Rebekka, et al.
Publicado: (2021)